Loading...
Cost–Utility of First-Line Actinic Keratosis Treatments in Finland
INTRODUCTION: Cost–utility assessment of first-line actinic keratosis (AK) treatments for max 25 cm(2) AK field. METHODS: A probabilistic, 2-year decision tree model was used to assess costs, quality-adjusted life-years (QALY), incremental cost-effectiveness ratio (ICER), cost-effectiveness efficien...
Na minha lista:
| Udgivet i: | Adv Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Healthcare
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449383/ https://ncbi.nlm.nih.gov/pubmed/26006101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0211-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|